ASHLEY SIX: Open Payments
NPI 1912598483 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,802 in 108 payments from 41 companies in 2025. Trend: 2023 $3,459 · 2024 $2,823 · 2025 $2,802
Food & beverage: $2,703Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $289 |
| E.R. Squibb & Sons, L.L.C. | 7 | $187 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $177 |
| AstraZeneca Pharmaceuticals LP | 7 | $174 |
| Daiichi Sankyo Inc. | 7 | $173 |
| Merck Sharp & Dohme LLC | 5 | $152 |
| ABBVIE INC. | 5 | $139 |
| Janssen Biotech, Inc. | 5 | $117 |
| Incyte Corporation | 1 | $99 |
| Rigel Pharmaceuticals, Inc. | 4 | $83 |
Products named: Enhertu, KISQALI, KEYTRUDA, Nubeqa, OPDIVO, Fabhalta, TAVALISSE, VERZENIO.
Industry payments across TX — which companies pay providers there.
